Ionis Pharmaceuticals, Inc. Common Stock (IONS) is a publicly traded Healthcare sector company. As of July 6, 2026, IONS trades at $82.46 with a market cap of $13.52B and a P/E ratio of 81.80. IONS moved +0.71% today. Year to date, IONS is +3.58%; over the trailing twelve months it is +87.66%. Its 52-week range spans $23.95 to $86.74. Analyst consensus is strong buy with an average price target of $104.61. Rallies surfaces IONS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IONS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $82.46 |
| Market Cap | $13.52B |
| P/E Ratio | 81.80 |
| EPS | $1.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $86.74 |
| 52-Week Low | $23.95 |
| Volume | 274.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.06B |
| Net Income | $154.57M |
| Gross Margin | 98.35% |
19 analysts cover IONS: 0 strong buy, 17 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $104.61.